Hypofractionated Radiation Therapy for Treating Prostate Cancer High-Risk Features Following Radical Prostatectomy

NCT03570827 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

52

Enrollment

OTHER

Sponsor class

Conditions

Prostate Adenocarcinoma
Stage IIB Prostate Cancer AJCC v8
Stage III Prostate Cancer AJCC v8
Stage IIIA Prostate Cancer AJCC v8
Stage IIIB Prostate Cancer AJCC v8
Stage IIIC Prostate Cancer AJCC v8

Interventions

DRUG: Androgen Suppression
RADIATION: Hypofractionated Radiation Therapy
OTHER: Quality-of-Life Assessment
OTHER: Questionnaire Administration

Sponsor

Mayo Clinic